NFA
AVNS

Nationwide Fund Advisors’s Avanos Medical AVNS Stock Holding History

Nationwide Fund Advisors’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-113,394
Closed -$5.11M – 190
2017
Q3 		$5.11M Sell
113,394
-3,427
-3% -$146K 0.02% 1010
2017
Q2 		$4.59M Buy
116,821
+772
+0.7% +$29.2K 0.02% 1058
2017
Q1 		$4.42M Sell
116,049
-1,666
-1% -$64.9K 0.02% 1049
2016
Q4 		$4.35M Buy
117,715
+471
+0.4% +$16.8K 0.02% 1062
2016
Q3 		$4.06M Buy
117,244
+3,137
+3% +$110K 0.02% 1076
2016
Q2 		$3.71M Buy
114,107
+5,648
+5% +$173K 0.02% 1090
2016
Q1 		$3.13M Buy
108,459
+1,572
+1% +$41.9K 0.01% 1149
2015
Q4 		$3.57M Buy
106,887
+493
+0.5% +$15.3K 0.02% 1100
2015
Q3 		$3.03M Sell
106,394
-15,300
-13% -$534K 0.01% 1165
2015
Q2 		$4.93M Buy
121,694
+45,059
+59% +$2.02M 0.02% 972
2015
Q1 		$3.77M Buy
76,635
+619
+0.8% +$28.7K 0.02% 1120
2014
Q4 		$3.46M Buy
+76,016
New +$2.99M 0.01% 1138

Other funds holding AVNS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Nationwide Fund Advisors's AVNS Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Avanos Medical (AVNS) in Q4 2017, closing a stake of 113,394 shares — an estimated $5.11M sold.

Nationwide Fund Advisors first reported a position in AVNS in Q4 2014 and held it in 12 quarters. The position peaked at $5.11M in Q3 2017. 350 funds tracked by Wall St. Rank hold AVNS as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Avanos Medical position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 113,394 Avanos Medical shares in Q4 2017, an estimated $5.11M.
  • Nationwide Fund Advisors first reported a position in Avanos Medical in Q4 2014 and held it in 12 quarters.
  • Nationwide Fund Advisors's Avanos Medical position peaked at $5.11M in Q3 2017.
  • 350 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.